OS Therapies Granted Final Type C Meeting by U.S. FDA and pre-MAA Meeting by U.K. MHRA for OST-HER2 in the Prevention or Delay of Recurrent, Fully Resected, Pu…

Final FDA Type C Meeting December 11, 2025 - biomarker data to be availableOctober 10, 2025 FDA/Osteosarcoma Institute ...
Hackaday

C Project Turns Into Full-Fledged OS

While some of us may have learned C in order to interact with embedded electronics or deep with computing hardware of some sort, others learn C for the challenge alone. Compared to newer languages ...